Variant report
Variant | nsv1034960 |
---|---|
Chromosome Location | chr6:55152655-55243149 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:259)
- CpG islands (count:244)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr6:55234172-55234222 | PrEC | prostate: | n/a |
2 | chr6:55234172-55234222 | BE2_C | brain: | n/a |
3 | chr6:55234085-55234135 | NHBE | bronchial: | n/a |
4 | chr6:55190909-55190959 | HRCEpiC | kidney: | n/a |
5 | chr6:55190909-55190959 | HNPCEpiC | eye: | n/a |
6 | chr6:55234172-55234222 | Hela-S3 | cervix: | n/a |
7 | chr6:55190909-55190959 | PFSK-1 | brain: | n/a |
8 | chr6:55192049-55192099 | HCT-116 | colon: | n/a |
9 | chr6:55190909-55190959 | AG09319 | gingival: | n/a |
10 | chr6:55192049-55192099 | HL-60 | blood: | n/a |
11 | chr6:55192049-55192099 | HPAEpiC | pulmonary alveolar: | n/a |
12 | chr6:55192049-55192099 | HMEC | breast: | n/a |
13 | chr6:55234085-55234135 | GM12891 | blood: | n/a |
14 | chr6:55192049-55192099 | AG09319 | gingival: | n/a |
15 | chr6:55234085-55234135 | A549 | lung: | n/a |
16 | chr6:55234172-55234222 | GM06990 | blood: | n/a |
17 | chr6:55190909-55190959 | Hela-S3 | cervix: | n/a |
18 | chr6:55192049-55192099 | MCF-7 | breast: | n/a |
19 | chr6:55192049-55192099 | HRCEpiC | kidney: | n/a |
20 | chr6:55190909-55190959 | Hepatocyte | liver: | n/a |
21 | chr6:55190909-55190959 | MCF10A-Er-Src | breast: | n/a |
22 | chr6:55234172-55234222 | NT2-D1 | testis: | n/a |
23 | chr6:55234085-55234135 | HCF | heart: | n/a |
24 | chr6:55190909-55190959 | HRE | kidney: | n/a |
25 | chr6:55234172-55234222 | SK-N-SH_RA | brain: | n/a |
26 | chr6:55234085-55234135 | HCM | heart: | n/a |
27 | chr6:55234172-55234222 | BJ | skin: | n/a |
28 | chr6:55192049-55192099 | HCPEpiC | choroid plexus: | n/a |
29 | chr6:55234172-55234222 | AG09309 | skin: | n/a |
30 | chr6:55192049-55192099 | NB4 | blood: | n/a |
31 | chr6:55190909-55190959 | PANC-1 | pancreas: | n/a |
32 | chr6:55234085-55234135 | Hela-S3 | cervix: | n/a |
33 | chr6:55192049-55192099 | GM12891 | blood: | n/a |
34 | chr6:55234085-55234135 | K562 | blood: | n/a |
35 | chr6:55192049-55192099 | IMR90 | lung: | fetal |
36 | chr6:55234085-55234135 | HIPEpiC | eye: | n/a |
37 | chr6:55234172-55234222 | ProgFib | skin: | n/a |
38 | chr6:55234085-55234135 | IMR90 | lung: | fetal |
39 | chr6:55234085-55234135 | HL-60 | blood: | n/a |
40 | chr6:55192049-55192099 | H1-hESC | embryonic stem cell: | embryo |
41 | chr6:55192049-55192099 | Hela-S3 | cervix: | n/a |
42 | chr6:55192049-55192099 | GM12878 | blood: | n/a |
43 | chr6:55234172-55234222 | HL-60 | blood: | n/a |
44 | chr6:55190909-55190959 | Jurkat | blood: | n/a |
45 | chr6:55234172-55234222 | SK-N-SH | brain: | n/a |
46 | chr6:55190909-55190959 | U87 | brain: | n/a |
47 | chr6:55190909-55190959 | BJ | skin: | n/a |
48 | chr6:55192049-55192099 | AG04450 | lung: | fetal |
49 | chr6:55234085-55234135 | AG10803 | skin: | n/a |
50 | chr6:55192049-55192099 | Jurkat | blood: | n/a |
No data |
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
GFRAL | TF binding region |
GFRAL | CpG island |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs571294915 | chr6:55157802-55157803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs370188066 | chr6:55157808-55157809 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs543780074 | chr6:55157861-55157862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs537020614 | chr6:55157878-55157879 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs144040406 | chr6:55157892-55157893 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs187129117 | chr6:55157921-55157922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs2653360 | chr6:55158000-55158001 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs189919181 | chr6:55158002-55158003 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs150245063 | chr6:55158052-55158053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79145752 | chr6:55158066-55158067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs182488839 | chr6:55158105-55158106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs113454183 | chr6:55158166-55158167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs149406944 | chr6:55158211-55158212 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs558007497 | chr6:55158220-55158221 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs114536346 | chr6:55158308-55158309 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs543443986 | chr6:55158325-55158326 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs144649723 | chr6:55158354-55158355 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs187063279 | chr6:55158362-55158363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs529322644 | chr6:55158377-55158378 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs542829941 | chr6:55158460-55158461 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs559554161 | chr6:55158465-55158466 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs148655709 | chr6:55158467-55158468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs551724693 | chr6:55158481-55158482 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs538371548 | chr6:55158493-55158494 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs372969796 | chr6:55158512-55158513 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs189897760 | chr6:55158554-55158555 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs530560310 | chr6:55158557-55158558 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs376199285 | chr6:55158563-55158564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs539488181 | chr6:55158568-55158569 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371319198 | chr6:55158570-55158571 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs142883192 | chr6:55158641-55158642 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs535936073 | chr6:55158674-55158675 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs572557405 | chr6:55158675-55158676 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs147701058 | chr6:55158700-55158701 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs200044761 | chr6:55158711-55158712 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs386701359 | chr6:55158712-55158713 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs2653362 | chr6:55158713-55158714 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs558072620 | chr6:55158720-55158721 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs377457368 | chr6:55158729-55158730 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs371153462 | chr6:55158738-55158739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs541784486 | chr6:55158742-55158743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs555296071 | chr6:55158749-55158750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs528389450 | chr6:55158789-55158790 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs577877037 | chr6:55158827-55158828 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs543802390 | chr6:55158854-55158855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190415110 | chr6:55158882-55158883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557043642 | chr6:55158898-55158899 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550445166 | chr6:55164200-55164201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs560441851 | chr6:55164216-55164217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs535656705 | chr6:55164221-55164222 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Leukemia | 21518781 | CNVD |
Cancer | 21637783 | CNVD |
Facial dysmorphism | 22105932 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Breast cancer | 21264507 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 16751803 | CNVD |
Bladder cancer | 19088036 | CNVD |
Wilms tumour | 21544195 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Biliary cancer | 19435499 | CNVD |
Malaria | 21533027 | CNVD |
Retinoblastoma | 19183342 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 21858162 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 21448237 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 22495311 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Cancer | 21183584 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Gastric cancer | 17908304 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Neuroblastoma | 16790693 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Osteosarcoma | 16790693 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Lung cancer | 18438408 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Breast cancer | 17603634 | CNVD |
Neurocytoma | 17123091 | CNVD |
Systemic lupus erythematosus | 17503323 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Breast cancer | 16608533 | CNVD |
Melanoma | 18172304 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Neuroblastoma | 19686582 | CNVD |
Neuroblastoma | 17289879 | CNVD |
Breast cancer | 17899364 | CNVD |
Breast cancer | 17133270 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Colorectal cancer | 16912164 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 20164919 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr6:55157800-55159000 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
2 | chr6:55164200-55164800 | Enhancers | Fetal Heart | heart |
3 | chr6:55164200-55165000 | Enhancers | Fetal Lung | lung |
4 | chr6:55164400-55164800 | Enhancers | Gastric | stomach |
5 | chr6:55164800-55165600 | Enhancers | Fetal Brain Male | brain |
6 | chr6:55164800-55167400 | Weak transcription | Fetal Heart | heart |
7 | chr6:55184800-55185400 | Enhancers | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
8 | chr6:55184800-55185600 | Enhancers | Fetal Heart | heart |
9 | chr6:55184800-55185800 | Enhancers | Placenta Amnion | Placenta Amnion |
10 | chr6:55185000-55185200 | Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
11 | chr6:55185200-55185600 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
12 | chr6:55185600-55186000 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
13 | chr6:55192000-55192400 | Active TSS | Adipose Nuclei | Adipose |
14 | chr6:55205400-55206200 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
15 | chr6:55217800-55218200 | Enhancers | Fetal Heart | heart |
16 | chr6:55233800-55234400 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
17 | chr6:55234000-55234200 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
18 | chr6:55234000-55234400 | Active TSS | HUES6 Cell Line | embryonic stem cell |
19 | chr6:55234000-55234400 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
20 | chr6:55234600-55235000 | Enhancers | Spleen | Spleen |
21 | chr6:55235000-55235400 | Weak transcription | Spleen | Spleen |
22 | chr6:55235400-55235800 | Enhancers | Spleen | Spleen |